Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
however, they cannot be on the preclusion list
Results are gradual, so consistent use is important
Why this matters Lp(a) is a genetically determined, causal risk factor for ASCVD, yet targeted therapies are not yet widely available
It focused on individual-level randomized clinical trial (RCT) data of GLP1-RA from the HARMONY program [Liraglutide (389 individuals) and Albiglutide (1,682 individuals)], the PRIBA study [Liraglutide (397 individuals), exenatide (223 individuals), and Tayside & Fife (415 individuals)
Last Update: 03/25/2022
The Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R pathways that influence medication response and metabolic sensitivity, not bruising directly
US$ 24.84
US$ 19.98
US$ 27.13
US$ 23.24
US$ 20.26
